We should stop acting as if Big Pharma is the big villain in American health care
tPA is a regular staple of medicine, given to people within hours of suffering a stroke. Scientists discovered tPA's existence in animals in 1947. Over the course of four decades, through continued research, the pharmaceutical industry turned tPA into a life-saving drug for stroke victims.
Advertisement
In 2016, after a massive influx of blood clots into my lungs, doctors gave me tPA. The results were rapid and life saving. Having been given 24 hours to live, I am still here, now taking Xarelto, a pill that daily thins my blood without the bruising associated with Coumadin, the most common blood-thinning medication.
Tagrisso received expedited approval from the Food and Drug Administration in 2015, just months before doctors confirmed my wife had epidermal growth factor receptor mutations that caused her to have a genetic form of lung cancer. Her doctor, who also helped develop Tagrisso, fought to get my wife on the medicine. At the time, he concluded, backed by research, that my wife would have two years before the cancer started growing again. She is still here, one of the longest surviving patients on Tagrisso. Researchers have used her case as evidence to expand the drug's availability.
It is easy to vilify the industry. Americans get expensive medical bills and regularly battle insurance companies for drug approvals. Sometimes drugs are approved, then declined. Some have embraced the conspiracy that doctors and drug makers collude to put people on medicines. In reality, virtually every doctor wants patients to make lifestyle changes, but many patients just want the pill. This is not the fault of drug makers. We are the problem when we would rather take the injection or the pill than make the lifestyle change.
Advertisement
I am fortunate that I have really good insurance. But even with good insurance, my wife and I experience the frustrations so many Americans share. When the new year turns over, the headaches return. This year, my Xarelto went from $10 to $580 per month for 30 pills. It will be that much the next few months until I have met a deductible.
My wife's Tagrisso is roughly $22,000 a month. With her quarterly cancer scans, just recently adjusted to every four months, we meet her and our family deductible quickly, and insurance has never charged us more than $100 in a month for her Tagrisso. Normally, we pay $20 a month.
But every year, as soon as January rolls around, my wife struggles to renew her prescription with the specialist pharmacy that has a contract with our insurance company. Every year, my wife's anxiety builds as she gets denied the medicine she needs to live and then has someone find an error in her claim, before she finally receives the medicine. For eight years, she has fought this battle annually.
Health insurance likewise causes me anxiety. We need it and, as a result, my job is important. As a conservative talk radio host known to openly criticize the president, I have faced organized mobs of online activists that have tried to get me fired, at the cost of my health insurance. The mobs have not deterred me, but I do understand the anxiety others have over losing their insurance. Every few years, as my job contract is up for renewal, my family's anxiety goes up. I am, to a degree, deprived of negotiating flexibility with my job because without it, our access to life-saving drugs would become vastly more costly.
Advertisement
Americans tend to pay more for prescription drugs than people in other countries. Those countries often subsidize drug costs. To Americans this is unfair. Big Pharma gets blamed. Newly confirmed Health and Human Services Secretary Robert F. Kennedy Jr. has, in part, gained traction among many Americans for capitalizing on and advancing attacks against the industry, building on American distrust of the health care system. The problem, however, is not really Big Pharma but the convoluted mess of American public and private insurance systems.
Many Americans cheered for
A free-market system could and should provide a saner, more streamlined, and affordable system. But the public, like the political parties, is divided over more or less government control and fewer or more mandates. The government cannot provide clarity or direction for private insurance and medical and pharmaceutical costs because Americans themselves cannot agree.
Government should at least be willing to provide multiple avenues that could, through each path, provide simplicity and more humanity to a system that is too often needlessly faceless and Byzantine.
Advertisement
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
RFK Jr.'s Public Health Plan? Get Every American to Buy a Wearable Device
PCMag editors select and review products independently. If you buy through affiliate links, we may earn commissions, which help support our testing. Health and Human Services Secretary Robert F. Kennedy Jr. wants everyone to wear a smartwatch, fitness tracker, or other piece of wearable health tech as part of his "Make America Healthy Again" (MAHA) agenda. "My vision is every American is wearing a wearable within four years," he told a House subcommittee today. "It's a way of people taking control over their own health. They can take responsibility. They can food is doing to their glucose levels, their heart rates, and a number of other metrics as they eat it." It's the same message Kennedy put out a month ago when he met with several health tech CEOs, including the heads of Whoop, Function Health, knownwell, Talkiatry, Season Health, Turquoise Health, and Hippocratic AI, according to STAT reporter Mario Aguilar. These companies stand to benefit from a government-backed push for Americans to buy their products, and Kennedy plans to soon kick off "one of the biggest advertising campaigns in HHS history to encourage Americans to use wearables," he told House lawmakers today. Wearables are growing rapidly. These days, they do far more than track steps; they monitor vitals, sleep, and nutrition. Many wearables can also detect serious conditions like atrial fibrillation (AFib). Last fall, the Federal Drug Administration approved Apple's addition of sleep apnea monitoring to the Apple Watch. Earlier this year, the company launched the Apple Health Study, "to further understand how technology—including iPhone, Apple Watch, and AirPods—can play a role in advancing and improving physical health, mental health, and overall wellbeing." Wearables could outsource some of the burden of monitoring the public's health to private companies and individuals rather than through government programs. However, that comes with personal data-collection risks, depending on how HHS and Kennedy plan to use or monitor a wearables-focused program. (CBS News reports that Kennedy plans to use data from personal fitness trackers and smartwatches to study autism.) Kennedy, meanwhile, is also planning major job cuts, promising to "save taxpayers an estimated $1.8 billion per year through a reduction in workforce," according to his prepared testimony. "Our reductions have focused on matching HHS staffing levels to the size of HHS prior to the COVID-19 pandemic, which saw an approximate 15% increase in the number of employees," he says.
Yahoo
an hour ago
- Yahoo
White House sends Dr. Oz to calm Senate nerves
The Senate Republican megabill is ailing. The White House thinks it has a doctor for that. Dr. Mehmet Oz, the celebrity surgeon best known for dispensing medical advice on television and now a top Trump health official, has emerged as the administration's go-to salesman for the sweeping Medicaid overhaul at the center of the GOP's legislative ambitions. Oz is increasingly pressing Republicans to back controversial cuts to the health program for low-income Americans, trekking to Capitol Hill several times in recent weeks to push for their support. He's privately counseled Republican senators and governors nervous over the potential fallout for their home states, and publicly promoted the far-reaching changes in a flurry of interviews. And as the White House and Congress race to meet a self-imposed July 4 deadline to pass the legislation, officials are betting that Oz's medical credentials — and his personal star power — can convince Republicans and their constituents to embrace the legislation despite warnings it will cost millions of people their health care coverage. "The more he can be out talking to members, and just in general, about the changes we're making and why they're so important and good is very helpful," said Sen. John Hoeven (R-N.D.), who has urged senior White House aides to deploy Oz more frequently in the coming days. "We think we've put together a good product, but there's others that we're still working to get on board." The megabill push represents the most visible role Oz has taken since joining the administration in April as Medicaid and Medicare chief, where he oversees an agency responsible for more than 160 million Americans' health care despite having little government or policymaking experience. It's also perhaps the toughest sales job of his career, requiring Oz to sway skeptical Republicans in favor of policies that are projected to eliminate health insurance for 16 million people — many of whom live in red states. Several Republicans remain wary of provisions that could cut insurance coverage and upend the finances of hospitals in their states. They've bristled at the efforts by Oz and others to downplay the tax-and-spending bill's implications, threatening to withhold their votes over worries it would decimate access to care where it's most needed. "Our goal here needs to be to protect rural hospitals and make sure that they can keep their doors open," said Sen. Josh Hawley (R-Mo.), one of a handful of holdouts who has expressed reservations about the depth of the Medicaid cuts. At the same time, a separate GOP faction has demanded deeper cuts to government spending, with some taking their case this week directly to President Donald Trump. And among the public, polls show only a small minority of Americans support the overall bill. The White House is nevertheless counting on Oz to play a central role in building support for the legislation, calculating that he has both the health care background and the bedside manner to assuage lawmakers' policy concerns. A cardiothoracic surgeon by training, Oz became a daytime television fixture first as a health expert for The Oprah Winfrey Show before helming his own health and wellness show for more than a decade. A longtime Trump friend who frequently speaks with the president, the 65 year old has also maintained close ties to some Republican senators from his own failed run for office just a few years ago. On Monday, Oz met with Senate Republican chiefs of staff to push for a decision on a so-called provider tax provision that has proven particularly politically divisive, while also trying to dissuade them from seeking new, deeper Medicaid cuts. The session followed an appearance last week at GOP senators' group lunch to pitch the merits of the bill's health care provisions. 'He's a very big asset in getting us across the finish line,' said a White House official, granted anonymity to discuss internal strategy. 'He has a lot of credibility to go into these lawmaker discussions, to talk to them and hear concerns out and then give the administration's viewpoint." Within the administration, Oz helped shape the White House's public messaging on Medicaid, at various points blaming "lots of lobbyists" for fueling criticism of the bill, while downplaying its impact on health coverage across a series of television interviews — even amid nonpartisan projections that hundreds of billions of dollars would be cut from the safety net program. 'There is no scenario, not in this bill, not in anywhere I've seen, where we're not spending more money on Medicaid,' Oz said in a recent Newsmax interview. Those aggressive performances have won praise among Trump officials, who dispatched him at times to help lawmakers and other allies workshop their own talking points. The work has also raised Oz's standing in the White House, where senior aides have been impressed by what two White House officials familiar with the dynamics and granted anonymity to discuss them described as his willingness to be a team player in government after decades as a high-profile celebrity. "For over a decade, Dr. Oz developed a personal rapport with millions of Americans who tuned into his iconic TV show about health and wellness," White House spokesman Kush Desai said in a statement, adding that as CMS administrator he's "leveraging the immense intellect and telegenic charm he used to build that following to now help President Trump deliver on his mandate of protecting and preserving Medicaid by slashing waste, fraud, and abuse.' Yet as the megabill hits the home stretch, the persistent divide among Republican lawmakers has also exposed the limits of his salesmanship. Despite overseeing the Medicaid program and facing the task of enacting whatever policy is signed into law, Oz — barely three months into his first government job — has had little direct control over the specifics of the policy negotiations. Those details have instead been coordinated largely between White House domestic policy aides and Republican leaders on the Hill. Hawley — who briefly raised concerns about Oz during his confirmation process over the surgeon's past support for gender-affirming care — on Tuesday said he hasn't talked with Oz about his Medicaid concerns and saw little value in meeting with him. 'He's not the decisionmaker,' he said. 'The president is.' That distance has limited his ability to win over skeptics across the health care industry, including hospital groups that have been particularly outspoken in drumming up concerns about the bill's impact on Medicaid. In one private meeting with hospital representatives earlier this month, Oz listened as they detailed the sprawling financial consequences for providers should Republicans forge ahead with major changes to Medicaid, according to a person in the room. But he had little to offer in response, insisting primarily that the GOP needed to find ways to limit the government's health spending. "I don't know what he believes," said the person, who was granted anonymity to detail the closed-door discussion. "He's a real bright guy and everything, but he doesn't have control of the policy." Oz now faces an even trickier situation with the politically delicate provider tax that's divided Republicans on the Hill, jeopardizing the race to the party's July 4 deadline. After Senate lawmakers debuted a deeper funding cut than what Republicans proposed in the House, Oz publicly defended the effort, blasting the existing arrangements between states and hospitals as a form of "legalized money laundering" that the administration needs to remedy, and breaking with Hawley and other GOP skeptics. "I would disagree that that money goes to rural hospitals," Oz said in a CNN appearance. "The reality is that extra money that's left over goes to hospitals that are better connected, the hospitals with the biggest lobbyists and the best ability to influence what happens in the state capitals." Yet behind closed doors days later, Oz struck a more measured note, nudging Senate GOP staffers instead to stick to the language laid out by the House. "He is a really gifted communicator," said Avik Roy, chair of the Foundation for Research on Equal Opportunity and a longtime conservative policy expert. "He may exceed people's expectations. But obviously what matters to some degree is what the policy is. And is the policy something that ordinary people are going to buy as a good policy?"
Yahoo
an hour ago
- Yahoo
Medicaid cuts in GOP megabill would hurt COPD patients
The deep cuts to Medicaid outlined in President Trump's budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine Dexter (D-Ore.) said Tuesday at The Hill's 'Matters of Life and Breath: Championing COPD Care' event. COPD is a progressive lung disease that makes it difficult to breathe. It is often caused by prolonged exposure to smoke or air pollution and is one of the leading causes of death in the U.S., according to the American Lung Association. 'I believe we are setting ourselves up for a disaster,' Dexter said at Tuesday's event, which was sponsored by AstraZeneca. Trump's 'big, beautiful bill' proposes paying for expiring tax cuts by slashing Medicaid, the joint federal and state program that offers health insurance to low-income Americans. The bill would reduce federal Medicaid spending by $793 billion over the next 10 years and would result in 10.3 million fewer people enrolling in the program by 2034, according to the Congressional Budget Office. That number also represents 1.3 million older people with Medicare who are known as 'dual-eligible individuals,' according to the health care policy nonprofit KFF. Dexter said she worries about how the proposed cuts would impact rural hospitals and their ability to provide care to her fellow Oregonians. Rural hospitals typically have a slimmer profit margin than those located in urban areas since they tend to be smaller and able to see fewer patients. Medicaid is the 'financial backbone' that keeps many of these hospitals operating, according to the Center for American Progress. Dexter worries that some rural hospitals in Oregon will be forced to close if the budget reconciliation bill passes the Senate with the proposed Medicaid cuts. Those closures could force sick Oregonians to travel even farther to receive care or turn to already overwhelmed emergency rooms for urgent care, she said. 'This is a master plan on how to break a system,' Dexter said. Grace Anne Dorney Koppel, president of the Dorney-Koppel Foundation, agreed with Dexter. Koppel has COPD herself. She was diagnosed with COPD 24 years ago, and at the time, she was told by physicians that she only had a short time to live. Treatment for the condition has advanced since she was diagnosed more than two decades ago, but the Medicaid cuts proposed in Trump's reconciliation bill threaten some of that progress, she said. If passed, the bill will hurt COPD patients in low-income communities, particularly in states like Kentucky, Mississippi and West Virginia, which have high rates of the condition, according to the Centers for Disease Control and Prevention. 'It will be a death blow,' Koppel said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
